Background Although certain forms of end-stage lung disease are debilitating, whether the
associated mortality rate exceeds that of transplantation is unclear. We undertook analysis to …

Background Because of the assumed beneficial effect of lung transplantation on survival,
controlled trials to assess the therapeutic benefit of lung transplantation are considered to be …

Background: Lung transplantation has become an established procedure for treating
patients with endstage lung disease, resulting in broadening criteria for recipient selection …

Background Lung transplantation has been available as therapy for end-stage lung disease
since the early 1980s, but survival after transplantation remains poor, with continued …

The lung transplantation candidate population is heterogeneous and survival benefit has not
been established for all patient groups. UK data from a cohort of 1997 adult (aged≥ 16), first …

Background: Increased referral for lung transplantation, persistent shortage of donor lungs,
and moderate transplant outcome call not only for adequate listing criteria, but also for an …

Rationale: Lung transplantation is an accepted and increasingly employed treatment for
advanced lung diseases, but the anticipated survival benefit of lung transplantation is poorly …

Background: The appropriate age to perform bilateral, sequential lung transplants (BSLT) in
patients with chronic obstructive pulmonary disease (COPD) remains controversial …

Present criteria for donor-lung selection exclude more than 85% of lungs. We aimed to
establish if potentially suitable lungs are rejected for transplantation. We obtained 29 pairs of …

ContextPatients with cystic fibrosis (CF) are the second largest group of lung transplant
recipients in the United States. The survival effect of transplantation on a general CF …